Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Morgan Stanley Downgrades Core Laboratories to Underweight, Announces $20 Price Target

Morgan Stanley analyst Connor Lynagh downgrades Core Laboratories (NYSE:CLB) from Equal-Weight to Underweight and announces $20 price target.
byBenzinga Newsdesk
September 26, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Morgan Stanley analyst Connor Lynagh downgrades Core Laboratories (NYSE:CLB) from Equal-Weight to Underweight and announces $20 price target.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Asia Dips, Eurozone Opens Lower While Crude Trades Below $90 – Global Markets Today While US Was Sleeping

By Akanksha Bakshi
September 26, 7:07 AM
On Monday, September 25, the U.S. stock markets gained, breaking a four-day losing streak. In the S&P 500, energy led with a 1.3% increase, followed by materials which rose by 0.8%. Consumer staples, however, declined by 0.4%. Investors are now looking to economic data and insights from the Federal Reserve to gauge potential interest rate trends.

ADIV